You are viewing: France ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The France ECMO Machines Market was valued at $15.87 Million in 2025 and projected to reach to $20.84 Million by 2030, representing a compound annual growth rate of 5.6%. France's ECMO machines market is poised for sustained growth through 2030, driven by increasing adoption in critical care settings and advancements in healthcare technology.

France ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France ECMO Machines Market Trends and Insights

  • This steady expansion reflects France's advancing healthcare infrastructure and increasing adoption of extracorporeal membrane oxygenation technology in critical care settings.
  • France's market growth is driven by rising demand for advanced cardiac and respiratory support solutions in hospitals and specialized cardiac centers across the country. The French ECMO market benefits from strong healthcare investment, aging population demographics, and growing prevalence of cardiovascular and respiratory conditions requiring intensive care intervention.
  • France's regulatory environment and reimbursement policies support the deployment of ECMO devices in major medical institutions.
  • Between 2025 and 2030, France is expected to see increased clinical adoption and expanded patient access to ECMO therapy, positioning the country as a key market within the European ECMO landscape..

Key Market Statistics

  • CAGR (2025-2030) 5.6% CAGR
  • Market Size, 2025 ~USD 15.87 Million
  • Forecast, 2030 ~USD 20.84 Million
  • Country France

France ECMO Machines Market Overview

Market Size & Growth :

France's ECMO machines market is valued at USD 15.87 million in 2025, with projected growth to USD 20.84 million by 2030, demonstrating a steady CAGR of 5.6% over the forecast period.

Healthcare Infrastructure Advancement :

France's robust healthcare system and significant investments in critical care infrastructure are driving increased adoption of ECMO technology across major hospitals and specialized cardiac centers.

Critical Care Expansion :

Growing prevalence of cardiac and respiratory failures, coupled with enhanced ICU capabilities in French medical institutions, is accelerating demand for extracorporeal membrane oxygenation systems.

Regional Market Position :

France represents a significant European market for ECMO machines, supported by strong regulatory frameworks, reimbursement policies, and a well-established network of tertiary care facilities.

France ECMO Machines Market Dynamics

  • The French healthcare system's commitment to improving patient outcomes in severe cardiac and respiratory conditions supports market expansion.
  • Rising awareness among healthcare professionals and improved access to ECMO therapy in major urban centers will further accelerate market penetration. Government initiatives promoting advanced medical technologies and favorable reimbursement mechanisms are expected to enhance market dynamics.
  • Additionally, collaborations between French hospitals and international ECMO manufacturers will strengthen the competitive landscape.
  • The market's steady 5.6% CAGR reflects France's balanced approach to healthcare innovation and cost-effective critical care solutions..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • France's ECMO machines market is valued at USD 15.87 million in 2025 and will reach USD 20.84 million by 2030.
    • France's market is growing at a CAGR of 5.6%, driven by advanced healthcare infrastructure and rising critical care demand.
    • France's aging population and increasing cardiovascular disease prevalence are key growth drivers for ECMO adoption.
    • France's favorable reimbursement policies and regulatory framework support sustained market expansion through 2030.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    France ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    FRANCE: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS4.584.754.925.115.325.555.796.064.3
    HOSPITALS16.5217.2718.0918.9719.9421.0122.1623.435.3
    SPECIALTY CLINICS3.333.413.53.63.723.843.974.123.3
    TOTAL24.4325.4226.5227.6828.9830.3931.9333.614.9

    Target Audience

    • Medical Device Manufacturers : ECMO machine producers need France-specific market data to develop localized strategies, identify distribution partners, and optimize product offerings for French hospitals and cardiac centers.
    • Healthcare Investors & PE Firms : Investment professionals require detailed France market analysis to evaluate acquisition targets, assess growth potential, and make capital allocation decisions in the French critical care sector.
    • Hospital & ICU Administrators : French healthcare facility leaders need market insights to justify ECMO technology investments, benchmark against peer institutions, and plan critical care service expansion strategies.
    • Distributors & Healthcare Suppliers : Medical device distributors operating in France require market sizing and growth forecasts to optimize inventory management, negotiate supplier contracts, and identify emerging opportunities.
    • Healthcare Consultants & Analysts : Consulting firms and research analysts need France-specific ECMO market data to support client advisory services, competitive analysis, and strategic planning recommendations.

    Key Companies in the France ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise valuation data for France's ECMO market (USD 15.87M in 2025) with detailed 5-year projections, enabling accurate budgeting and investment planning for French market entry or expansion.
    • Competitive Landscape Intelligence : Understand France-specific competitive dynamics, key players, market share distribution, and strategic positioning within the French healthcare ecosystem to identify partnership and growth opportunities.
    • Regulatory & Reimbursement Insights : Gain comprehensive knowledge of French regulatory requirements, reimbursement policies, and healthcare system nuances that directly impact ECMO machine adoption and market accessibility.
    • Growth Driver Analysis : Identify France-specific factors driving 5.6% CAGR growth, including healthcare infrastructure investments, critical care demand trends, and technology adoption patterns unique to the French market.
    • Strategic Decision Support : Make informed decisions on market entry timing, product positioning, distribution strategies, and resource allocation specifically tailored to France's healthcare landscape and market maturity.

    Frequently asked questions

    What is the current size of the ECMO machines market in France?

    France's ECMO machines market is estimated at USD 15.87 million in 2025.

    What is the projected market size for ECMO machines in France by 2030?

    France's ECMO machines market is projected to reach USD 20.84 million by 2030.

    What is the growth rate of the ECMO market in France?

    France's ECMO machines market is growing at a CAGR of 5.6% from 2025 to 2030.

    What factors are driving ECMO market growth in France?

    Key drivers include France's aging population, rising cardiovascular disease prevalence, advanced healthcare infrastructure, and supportive reimbursement policies.

    How does France's ECMO market compare to other European countries?

    France represents a significant European ECMO market with steady growth supported by strong healthcare investment and clinical adoption in major medical institutions.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status